Eligibility required 13 prior lines including antiCD38 antibody and lenalidomide exposure, ECOG 02, and progression or nonresponse to the last regimen
Overall, the efficacy of these drugs ranges from 5 percent to 10 percent average weight loss and many are limited by their less-tolerated side effects. Whats coming down the pipeline
Additional adjustments for baseline use of antidiabetic drugs (SGLT-2 [sodium-glucose cotransporter 2] inhibitors, metformin, DPP-4 [dipeptidyl peptidase 4] inhibitors, insulin, -glucosidase inhibitors, sulfonylureas, thiazolidinediones) similarly did not change the results (model 3
Not required under normal lab conditions, but refrigeration is not harmful if temperature remains stable and above freezing
Two 5mg vials used sequentially provide better potency consistency than one 10mg vial used over eight weeks, even though the latter seems more cost-effective
Can I take it if I dont have diabetes